BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2095367)

  • 1. Characterization and partial purification of human epithelial transforming growth factor.
    Dunnington DJ; Scott RG; Anzano MA; Greig R
    J Cell Biochem; 1990 Dec; 44(4):229-39. PubMed ID: 2095367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and characterization of a novel transforming growth factor.
    Halper J; Moses HL
    Cancer Res; 1987 Sep; 47(17):4552-9. PubMed ID: 2887280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of growth of human carcinoma SW-13 cells by heparin and growth factors.
    Halper J; Carter BJ
    J Cell Physiol; 1989 Oct; 141(1):16-23. PubMed ID: 2777898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of transforming growth factor type e.
    Parnell PG; Wunderlich J; Carter B; Halper J
    J Cell Biochem; 1990 Feb; 42(2):111-6. PubMed ID: 2307712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of epithelial-type transforming growth factor by micro-preparative electrophoresis chromatography.
    Parnell PG; Carter BJ; Halper J
    Biotechniques; 1993 Apr; 14(4):591-3, 596. PubMed ID: 8476602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
    Ethier SP; Langton BC; Dilts CA
    Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplicity of transforming growth factors in human malignant effusions.
    Seo MK; Lynch KE; Podolsky DK
    Cancer Res; 1988 Apr; 48(7):1792-7. PubMed ID: 2894891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial tissue-derived growth factor-like polypeptides.
    Halper J; Moses HL
    Cancer Res; 1983 May; 43(5):1972-9. PubMed ID: 6572559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes.
    Zarnegar R; Michalopoulos G
    Cancer Res; 1989 Jun; 49(12):3314-20. PubMed ID: 2524251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a 15,000-molecular-weight form of immunoreactive transforming growth factor alpha in extracts of porcine pituitary.
    Riss TL; Sirbasku DA
    J Cell Physiol; 1989 Feb; 138(2):393-404. PubMed ID: 2918041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth factor production by human colon carcinoma cell lines.
    Anzano MA; Rieman D; Prichett W; Bowen-Pope DF; Greig R
    Cancer Res; 1989 Jun; 49(11):2898-904. PubMed ID: 2541895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of tumor cell growth-inhibiting factors from a human rhabdomyosarcoma cell line.
    Iwata KK; Fryling CM; Knott WB; Todaro GJ
    Cancer Res; 1985 Jun; 45(6):2689-94. PubMed ID: 3857121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a low molecular weight form of epithelial transforming growth factor.
    Dunnington D; Prichett W; Moyer M; Greig R
    Life Sci; 1990; 47(22):2059-63. PubMed ID: 2273942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of melanoma growth stimulatory activity.
    Richmond A; Thomas HG
    J Cell Physiol; 1986 Dec; 129(3):375-84. PubMed ID: 3465735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of autostimulatory and transforming growth factors from human melanoma cells.
    Richmond A; Lawson DH; Nixon DW; Chawla RK
    Cancer Res; 1985 Dec; 45(12 Pt 1):6390-4. PubMed ID: 3864531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two distinct tumor cell growth-inhibiting factors from a human rhabdomyosarcoma cell line.
    Fryling CM; Iwata KK; Johnson PA; Knott WB; Todaro GJ
    Cancer Res; 1985 Jun; 45(6):2695-9. PubMed ID: 2580626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factors produced by normal and neoplastically transformed rat liver epithelial cells in culture.
    Liu C; Tsao MS; Grisham JW
    Cancer Res; 1988 Feb; 48(4):850-5. PubMed ID: 3276400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
    Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK
    Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
    Fernandez-Pol JA; Klos DJ; Grant GA
    Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of transforming growth factors produced by the insulin-independent teratoma-derived cell line 1246-3A.
    Yamada Y; Serrero G
    J Cell Physiol; 1989 Aug; 140(2):254-63. PubMed ID: 2663884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.